Randomized Study of Two Doses of Oral Valacyclovir in Immunocompromised Patients With Uncomplicated Herpes Zoster

Completed · Not applicable

Conditions studied: Herpes Zoster, Immunologic Deficiency Syndromes

In brief

OBJECTIVES: I. Compare the efficacy and safety of two doses of oral valacyclovir in immunocompromised patients with uncomplicated herpes zoster. II. Compare quality of life, pain, and medical resource utilization in patients treated with these 2 regimens.

Key facts

Study ID

NCT00006131

Run by

National Center for Research Resources (NCRR)

People needed

66

Starts

1997-01-01

Last updated by the study team

2007-05-24

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Center for Clinical Studies — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.